<DOC>
	<DOC>NCT01859585</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy of Parecoxib and Ketorolac as a preemptive analgesia in patients undergoing lumbar spinal fusion.</brief_summary>
	<brief_title>Efficacy Parecoxib and Ketorolac as Preemptive Analgesia in Spine Fusion</brief_title>
	<detailed_description>A prospective, double-blinded randomized control trial. Randomly allocated patient undergoing posterior lumbar spinal fusion into 3 groups (n=32) to receive Parecoxib, Ketorolac and Placebo around 30 minutes prior to incised skin. Efficacy was assessed by visual analog scale score (0-10), total opioid consumption, complication and bleeding also recorded.</detailed_description>
	<mesh_term>Pain, Postoperative</mesh_term>
	<mesh_term>Ketorolac</mesh_term>
	<mesh_term>Ketorolac Tromethamine</mesh_term>
	<mesh_term>Parecoxib</mesh_term>
	<criteria>Patients undergoing lumbar spinal fusion for one to three levels ASA class I or II History of allergy to Sulfa group History of allergy to OPOID or NSAIDs Contraindicate to NSAIDs use History of coagulopathy or platelet disfunction</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>preemptive analgesia</keyword>
	<keyword>lumbar fusion</keyword>
	<keyword>Parecoxib</keyword>
	<keyword>Ketorolac</keyword>
</DOC>